Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Ramipril (Altace) is a long-acting oral angiotensin-converting enzyme (ACE) inhibitor indicated for the treatment of patients with essential hypertension or congestive heart failure after myocardial infarction. Ramipril also is indicated in cardiovascular risk reduction.

Drug Criteria & Outcomes: Ramipril formulary evaluation